Aytu Biopharma Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Aytu Biopharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.
/ 
Frequently asked questions
To buy Aytu Biopharma Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Aytu Biopharma Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Aytu Biopharma Inc. is AYTU:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Aytu Biopharma Inc. has its primary listing on NASDAQ (Small cap). You can trade Aytu Biopharma Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Aytu Biopharma Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Aytu Biopharma Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Aytu Biopharma Inc..